Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, 211198, China.
Department of Public Affairs Management, School of International Pharmaceutical Business, Pharmaceutical University, 211198, Nanjing, China.
BMC Public Health. 2023 Aug 11;23(1):1531. doi: 10.1186/s12889-023-16458-1.
Non-pharmacological interventions (NPIs) could be considered in the early management of prehypertensive population. This study aimed to evaluate the potential cost-effectiveness of NPIs and the budget impact of implementing NPIs on prehypertensive population in China and provide evidence of chronic disease management innovation for decision-makers.
Five NPIs including usual care, lifestyle, strengthen exercise, relaxation, and diet therapy were selected based on the practice of hypertension management in China. A nine-state Markov model was constructed to evaluate the lifetime costs and health outcomes of five NPIs and a non-intervention group from the perspective of Chinese healthcare system. The effectiveness of NPIs was obtained from a published study. Parameters including transition probabilities, costs and utilities were extracted or calculated from published literature and open-access databases. Sensitivity analyses were conducted to test the uncertainty of all parameters. The impact of duration of intervention was considered in scenario analyses. A budget impact analysis (BIA) was conducted to evaluate the total cost and the medical cost saving of a hypothetical nationwide implementation of potential cost-effective NPI in prehypertensive people. Management strategies including focusing on patients with specific ages or different CVE risk levels, and different duration of implementation were taken into consideration.
Strengthen exercise was the most cost-effective intervention with a probability of 78.1% under the given WTP threshold. Our results were sensitive to the cost of interventions, and the utility of prehypertension and hypertension. The duration of implementation had limited impact on the results. BIA results showed that the program cost was hefty and far more than the medical cost saving with the course of simulation time. Applying management strategies which focused on individual characteristics could largely reduce the program cost despite it remained higher than medical cost saving.
Strengthen exercise was a potential NPI that can be considered in priority for early management in prehypertensive population. Although early management can acquire medical cost saving, the related program cost can be quite hefty. Precise strategies which may help reduce the cost of early management should be taken into consideration in program design.
非药物干预(NPIs)可被视为高血压前期人群的早期管理手段。本研究旨在评估 NPIs 的潜在成本效益,以及在中国高血压前期人群中实施 NPIs 的预算影响,为决策者提供慢性病管理创新的证据。
基于中国高血压管理实践,选择了 5 种 NPIs,包括常规护理、生活方式、强化运动、放松和饮食疗法。构建了一个九状态 Markov 模型,从中国医疗保健系统的角度评估了五种 NPIs 和非干预组的终生成本和健康结果。NPIs 的有效性来自已发表的研究。参数包括转移概率、成本和效用,从已发表的文献和开放获取数据库中提取或计算。进行了敏感性分析以测试所有参数的不确定性。在情景分析中考虑了干预持续时间的影响。进行了预算影响分析(BIA),以评估在高血压前期人群中实施潜在成本效益的 NPIs 的全国性计划的总成本和医疗费用节省。考虑了针对特定年龄或不同 CVE 风险水平的患者以及不同实施持续时间的管理策略。
强化运动是最具成本效益的干预措施,在给定的 WTP 阈值下,其概率为 78.1%。我们的结果对干预成本和高血压前期和高血压的效用敏感。实施持续时间对结果的影响有限。BIA 结果表明,随着模拟时间的推移,该计划的成本高昂,远远超过医疗费用的节省。尽管计划成本仍然高于医疗费用节省,但应用侧重于个体特征的管理策略可以大大降低计划成本。
强化运动是一种潜在的 NPIs,可以优先考虑用于高血压前期人群的早期管理。虽然早期管理可以获得医疗费用节省,但相关计划成本可能相当高昂。在方案设计中应考虑采取有助于降低早期管理成本的精确策略。